We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+5.97%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$527M
AUM Growth
-$23M
(-4.2%)
Cap. Flow
-$51M
Cap. Flow
% of AUM
-9.68%
Top 10 Holdings %
Top 10 Hldgs %
55.85%
Holding
241
New
56
Increased
30
Reduced
100
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$48M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$37.2M |
| 3 |
Vanguard Consumer Staples ETF
VDC
|
+$5.33M |
| 4 |
Vanguard Information Technology ETF
VGT
|
+$4.68M |
| 5 |
Vanguard Consumer Discretionary ETF
VCR
|
+$4.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.7M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$49.7M |
| 3 |
SPDR Gold Trust
GLD
|
+$3.06M |
| 4 |
Kimberly-Clark
KMB
|
+$2.84M |
| 5 |
DISH
DISH Network Corp.
DISH
|
+$2.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.31% |
| 2 | Healthcare | 4.46% |
| 3 | Industrials | 4.11% |
| 4 | Energy | 3.15% |
| 5 | Real Estate | 2.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANTH
126
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $708K | 0.13% |
22,000
-8,232
| -27% | -$255K |
|
127
Macy's
M
$6.4B
| $704K | 0.13% |
16,280
-30,339
| -65% | -$1.42M |
|
128
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.78B
| $700K | 0.13% |
30,638
| – | – |
|
129
iShares MSCI Taiwan ETF
EWT
$10.4B
| $696K | 0.13% |
25,000
+10,000
| +67% | +$273K |
|
130
Oracle
ORCL
$362B
| $688K | 0.13% |
20,751
-54,123
| -72% | -$1.76M |
|
131
AT&T
T
$160B
| $674K | 0.13% |
26,373
-80,653
| -75% | -$2.12M |
|
132
ASE Group
ASX
$88.8B
| $669K | 0.13% |
+140,000
| New | +$597K |
|
|
MBT
133
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $668K | 0.13% |
30,000
| – | – |
|
134
PepsiCo
PEP
$185B
| $651K | 0.12% |
8,186
-16,558
| -67% | -$1.36M |
|
135
US Bancorp
USB
$100B
| $618K | 0.12% |
+16,894
| New | +$626K |
|
136
VanEck Short Muni ETF
SMB
$312M
| $606K | 0.12% |
34,600
-19,375
| -36% | -$338K |
|
137
Vanguard Real Estate ETF
VNQ
$39.2B
| $606K | 0.12% |
9,155
+4,162
| +83% | +$283K |
|
138
Coca-Cola
KO
$354B
| $600K | 0.11% |
15,838
-48,836
| -76% | -$1.93M |
|
139
Costco
COST
$411B
| $596K | 0.11% |
5,174
-14,018
| -73% | -$1.62M |
|
140
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $595K | 0.11% |
14,600
+247
| +2% | +$9.78K |
|
141
Merck
MRK
$315B
| $592K | 0.11% |
13,033
-33,618
| -72% | -$1.53M |
|
142
Simon Property Group
SPG
$73.4B
| $591K | 0.11% |
4,237
-1,116
| -21% | -$162K |
|
143
Abbott
ABT
$175B
| $582K | 0.11% |
17,541
-18,822
| -52% | -$660K |
|
|
FBR
144
DELISTED
Fibria Celulose Sa
FBR
| $576K | 0.11% |
50,000
+30,000
| +150% | +$346K |
|
145
Gyre Therapeutics
GYRE
$662M
| $566K | 0.11% |
135
| – | – |
|
146
Vanguard Total Bond Market
BND
$158B
| $563K | 0.11% |
6,966
+81
| +1% | +$6.52K |
|
|
AIV
147
Aimco
AIV
$377M
| $559K | 0.11% |
+150,136
| New | +$583K |
|
148
Amgen
AMGN
$198B
| $559K | 0.11% |
4,995
-10,888
| -69% | -$1.18M |
|
|
BMR
149
DELISTED
BIOMED REALTY TRUST INC
BMR
| $558K | 0.11% |
30,033
-35,000
| -54% | -$687K |
|
150
DuPont de Nemours
DD
$18.9B
| $549K | 0.1% |
5,645
-14,189
| -72% | -$1.32M |
|
Similar funds
EC
SFM
NHC
EQF
CCM
NEI
Bailard's Q3 2013 Portfolio in Review
As of Q3 2013, Bailard held 241 positions worth $527M, down 4.2% from $550M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Bailard withdrew a net $51M in Q3 2013, closing 27 positions and reducing 100 holdings. Its most notable exit was Ligand Pharmaceuticals, an estimated $2.43M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 8.1% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Bailard opened a new position in Invesco DB Commodity Index Tracking Fund worth $47.3M.
- Bailard's largest Q3 2013 buy was Invesco DB Commodity Index Tracking Fund: 1,837,601 shares worth $47.3M.
- Bailard added most to Vanguard Total Stock Market ETF in Q3 2013, an estimated $37.2M increase.
- Bailard's biggest Q3 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $50.7M.
- Bailard fully exited Ligand Pharmaceuticals in Q3 2013, selling an estimated $2.43M.
- Bailard's ten largest holdings make up 56% of its $527M portfolio in Q3 2013.
- Bailard opened 56 new positions and closed 27 in Q3 2013.
- Bailard's portfolio value fell 4.2% quarter-over-quarter to $527M.
Based on Bailard's 13F filing for Q3 2013, filed 28 Oct 2013.